An additional polycomb group protein, SUZ12 has also been shown to be overexpressed in bone marrow CD34+ cells from BP-CML patients, resulting from the activation of the non-canonical Wnt pathway (Pizzatti et al., 2010). Here, SUZ12 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.